Incubate Coalition

12/06/2021

Read Executive Director John Stanford's statement in response to President Biden's recent remarks on drug pricing in Build Back Better.

11/18/2021

Fighting AMR must be a national priority. To kick off AMR Awareness Week, which begins today, we're listening to E2 Making Medicine episode with Alfonso Chang, Managing Director of Relativity Healthcare Partners. Check it out here:

The fight against Antimicrobial Resistance (AMR) is challenging due to financial, ethical, and legislative issues. Combating infectious disease can prove to be a risky financial investment but much less in comparison to the global impact if solutions are not researched.

11/09/2021

"By ignoring what they [Congress] may have thought were minor details, they’re about to distort the entire drug-development ecosystem to society’s detriment." Read Peter Kolchinsky's op-ed in STAT News

Democrats' drug pricing bill will skew drug development toward expensive biologics and have other unintended consequences.

11/05/2021

Peter Kolchinsky discusses the harm of price control policies on the drug market in our newest episode of 🎙️ https://www.incubatecoalition.org/episode-10

11/04/2021

Read Executive Director John Stanford's statement on the drug price provisions included in the Build Back Better plan.

11/01/2021

Incubate Executive Director John Stanford, had a great conversation with Peter Kolchinsky, Managing Partner at RA Capital Management on the investor's paradox when it comes to investment in drug discoveries, and why insurance is so critical to patient accessibility and innovation. We're thrilled to be launching this episode TOMORROW, and hope you'll check it out on your favorite podcast streaming platform! 🎙️

10/28/2021

Many of the most exciting things in the biotech industry happen at an early stage. Really, really early- like your MIT senior year capstone project.

At least, that’s what happened to Daniel Carballo, Co-Founder & CEO at Encora Therapeutics, who speaks with Lindsay Androski, Founder, President, & CEO at Roivant Social Ventures, about this stunning founding story. 🎙️

https://www.incubatecoalition.org/podcast-announcements

10/25/2021

"To improve the quality of life, to improve the standard of care for millions of tremor patients- that is our North Star." Check out our newest episode of Making Medicine with Lindsay Androski, from Roivant Social Ventures, and Daniel Carballo from Encora Therapeutics 🎙️

10/20/2021

Incubate Policy Lab and Charles River Associates held a roundtable in July 2021, featuring distinguished economists, venture capitalists, a former CBO official, biotech executives, and other industry experts to discuss the CBO’s analysis of HR 3 and the economic impacts of drug price controls. Read the report by visiting our website:

10/19/2021

Listen to the MIT Takeover on today's newest episode of Making Medicine, featuring Incubate Board President Lindsay Androski, and Daniel Carballo, Founder of Encora Therapeutics 🎙️ https://podcasts.apple.com/us/podcast/mit-takeover-a-medtech-vc-partnership-working-to/id1567761258?i=1000539017696

10/14/2021

If you haven't yet, be sure to check out our newest episode of Making Medicine, featuring our Board Treasurer Janis Naeve, along with Brian Bradbury from Amgen and Alan Brookhart from NoviSci 🎙️https://www.incubatecoalition.org/podcast-announcements

10/07/2021

We're thrilled to be hosting our Averting Economic Disaster: Why Congress Should Defend our Region's Biopharmaceutical Sector event TOMORROW at 9 AM EST. Register today to hear experts discuss price control policies and their economic impacts: